Jenna L. Butner MD, MPH

Jenna L. Butner MD, MPHJenna L. Butner MD, MPHJenna L. Butner MD, MPH
  • Home
  • About
  • Publications
  • Contact
  • More
    • Home
    • About
    • Publications
    • Contact

Jenna L. Butner MD, MPH

Jenna L. Butner MD, MPHJenna L. Butner MD, MPHJenna L. Butner MD, MPH
  • Home
  • About
  • Publications
  • Contact

Peer-Reviewed Articles

Global Perspectives on Telemedicine-Enabled Medication for Opioid Use Disorder: Practices, Priorities, and BarriersGlobal overview of short-term alcohol policies: need for global exchange of experience and impact measurementUnderstanding the use of telemedicine across different opioid use disorder treatment models: A scoping reviewIn Support of the Decriminalization of Personal Drug and Paraphernalia Use and Possession: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use and Addiction)Spirituality and behavioural addictions: narrative reviewClinical progress note: Xylazine use and its sequelaeIn Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveysProvider and administrator attitudes and experiences with implementing telebuprenorphine during the COVID-19 pandemic: a mixed-methods surveyIn Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction)Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case ReportAn online global survey and follow-up expert groups on the scope and needs related to training, research, and mentorship among early-career addiction medicine professionalsTramadol, captagon and khat use in the Eastern Mediterranean Region: opening Pandora's boxHarm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspectivePrimary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 PandemicButtonReorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global SurveyTraining addiction counselors to deliver a brief psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigationOnsite treatment of HCV infection with direct acting antivirals within an opioid treatment programNon-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review

Psychology Today Blog

185 Madison Ave, Suite 1405

NEW YORK, NY, 10016



 

© 2026 Jenna Butner MD